Last reviewed · How we verify
Calcium Channel Blocker & Adenosine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Calcium Channel Blocker & Adenosine (Calcium Channel Blocker & Adenosine) — Singapore General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Calcium Channel Blocker & Adenosine TARGET | Calcium Channel Blocker & Adenosine | Singapore General Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Calcium Channel Blocker & Adenosine CI watch — RSS
- Calcium Channel Blocker & Adenosine CI watch — Atom
- Calcium Channel Blocker & Adenosine CI watch — JSON
- Calcium Channel Blocker & Adenosine alone — RSS
Cite this brief
Drug Landscape (2026). Calcium Channel Blocker & Adenosine — Competitive Intelligence Brief. https://druglandscape.com/ci/calcium-channel-blocker-adenosine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab